Results 251 to 260 of about 532,411 (388)

A Novel Sprayable Fibrinogen/Glycosaminoglycans/Collagen‐Based Bioink for Skin Wound Healing Applied by a Handheld Dual‐Head Airbrush

Advanced Healthcare Materials, EarlyView.
A dual‐head airbrush‐based spraying device, combined with a fibrinogen bioink enriched with glycosaminoglycans and collagen, enables the delivery of biomaterials and cells to promote wound healing. This system demonstrates effective skin regeneration in vitro and in vivo, with comparable results to autografts.
Paula Pleguezuelos‐Beltrán, Daniel Nieto‐García, Carlos Chocarro‐Wrona, Juan de Vicente, Patricia Gálvez‐Martín, José Manuel Entrena, Elena López‐Ruiz, Juan Antonio Marchal   +7 more
wiley   +1 more source

Infantile-onset Pompe disease entering adulthood: Insights from 2 decades of enzyme replacement therapy experience. [PDF]

Genet Med
Regmi N, Kenney-Jung D, Stafford G, Malinzak M, Spiridigliozzi GA, Boggs T, Koch RL, Smith PB, Case LE, Young SP, Jones HN, Kishnani PS.   +11 more
europepmc   +1 more source

Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges

Journal of Bone and Mineral Research, 2017
M. Whyte
semanticscholar   +1 more source

Cell Calcification Models and Their Implications for Medicine and Biomaterial Research

Advanced Healthcare Materials, EarlyView.
Calcification, is the process by which the tissues containing minerals are formed, occurring during normal physiological processes, or in pathological conditions. Here, it is aimed to give a comprehensive overview of the range of cell models available, and the approaches taken by these models, highlighting when and how methodological divergences arise,
Luke Hunter, Caterina Vanelli Coralli, Robert Dzhanaev, Aaron Morgan, Willi Jahnen‐Dechent, Sergio Bertazzo   +5 more
wiley   +1 more source

Home Enzyme Replacement Therapy in Gaucher Disease: A Review. [PDF]

J Clin Med
Kieć-Wilk B, Guijt P, Dan M, Abdelwahab M, Revel-Vilk S, Serratrice C, International Gaucher Alliance (IGA) and the International Working Group on Gaucher Disease (IWGGD).   +6 more
europepmc   +1 more source

Scheie syndrome: Enzyme replacement therapy does not prevent progression of cervical myelopathy due to spinal cord compression [PDF]

, 2009
Sabine Illsinger, Thomas Lücke, Hans Hartmann, Eugen Mengel, Wibke Müller‐Forell, Frank Donnerstag, Anibh M. Das   +6 more
openalex   +1 more source

Enzyme replacement therapy in India

Journal of Postgraduate Medicine, 2018
Muranjan, M, Karande, S
openaire   +2 more sources

Translational Considerations for Injectable Biomaterials and Bioscaffolds to Repair and Regenerate Brain Tissue

Advanced Healthcare Materials, EarlyView.
The repair and regeneration of brain tissue faces both biological and technical challenges. Injectable bioscaffolds offer new opportunities to stimulate tissue regrowth in the brain by recruiting neural stem cells. Here, the translational issues are reviewed that need to be address to advance this promising new therapeutic approach from the bench to ...
Michel Modo, Alena Kisel
wiley   +1 more source

Enzyme replacement therapy in infants and very young children with Gaucher disease using velaglucerase alfa: a single-center experience. [PDF]

Front Pediatr
Goker-Alpan O, Ivanova MM, Pathak R, Wright E.   +3 more
europepmc   +1 more source

Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients [PDF]

Christina S. Thornton, Barbara J. Waddell, Stephen E. Congly, Julianna Svishchuk, Ranjani Somayaji, Linda Fatovich, Debra Isaac, Karen Doucette, Kevin Fonseca, Steven J. Drews, Jamie Borlang, Carla Osiowy, Michael D. Parkins   +12 more
openalex   +1 more source